(Q34602545)

3 August 2017

1 reference

title

The significance of immunohistochemistry in the diagnosis and therapy of neoplasms (English)

1 reference

3 August 2017

1 reference

Bela Bodey

1

1 reference

PubMed ID

11955276

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Expert Opinion on Biological Therapy

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

4

1 reference

3 August 2017

371-393

1 reference

Pathology of small-cell lung cancer.

3 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The clinical significance of micrometastases and molecular metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

TP53 tumor suppressor gene: a model for investigating human mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Constitutional p53 mutations associated with brain tumors in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

p53 protein overexpression in astrocytic neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

p53: a frequent target for genetic abnormalities in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

p53 mutation in hepatocellular carcinoma after aflatoxin exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The p53 tumor suppressor gene in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenous aprt gene in CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

DNA mismatch repair enzyme activity and gene expression in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Angiogenesis as a target for tumor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Expression and distribution of vascular endothelial growth factor protein in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The biochemistry of cancer dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Expression of vascular endothelial growth factor in capillary hemangioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Embryonic angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Expression of bFGF and VEGF in brain astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Scatter factor and other regulators of cell mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Immunolocalization of granulocyte-colony-stimulating factor in human glial and primitive neuroectodermal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Hepatocyte growth factor: clinical implications in hepatobiliary pancreatic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

21 January 2018

Epidermal Growth Factor

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The type 1 (EGFR-related) family of growth factor receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Heregulin induces tyrosine phosphorylation of HER4/p180erbB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Requirement for neuregulin receptor erbB2 in neural and cardiac development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Identification of heregulin, a specific activator of p185erbB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Structure-function relationships for the EGF/TGF-alpha family of mitogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Differential expression of ARIA isoforms in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Multiple essential functions of neuregulin in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Epidermal growth factor promotes a neural phenotype in thymic epithelial cells and enhances neuropoietic cytokine expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Prognostic significance of ERBB3 overexpression in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

c-erbB-3 protein expression in ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Ectopic peptides released by a human melanoma cell line that modulate the transformed phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The long term prognostic significance of c-erbB-2 in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Significance of immunohistochemical c-erbB-2 product localization pattern for prognosis of primary human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

c-erbB-2 expression in benign and malignant breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

HER-2 oncogene amplification and overall survival of breast carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Expression of the ERBB3 gene product in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The erbB-3 gene in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

To die or not to die: an overview of apoptosis and its role in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Death in Embryonic Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Premature p34cdc2 activation required for apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Cell cycle and apoptosis: common pathways to life and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Apoptosis and the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Life, death, and the pursuit of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Regulation of apoptosis in immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Dicing with death: dissecting the components of the apoptosis machinery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Cell death: the significance of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Phagocyte recognition of cells undergoing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Induction of apoptosis in fibroblasts by c-myc protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Bcl-2: a repressor of lymphocyte death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Fas transduces activation signals in normal human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Lethal effect of the anti-Fas antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Purification and characterization of the Fas-ligand that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Defective maintenance of T cell tolerance to a superantigen in MRL-lpr/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Activation interferes with the APO-1 pathway in mature human T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Thymocyte apoptosis induced by p53-dependent and independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Caenorhabditis elegans gene ced-9 protects cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Mechanisms and genes of cellular suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Human ICE/CED-3 protease nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

p53 mutations increase resistance to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

p53 is required for radiation-induced apoptosis in mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The HER-2/neu oncogene in tumors of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Tumor therapy with targeted atomic nanogenerators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

The implications of angiogenesis for the biology and therapy of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Function and regulation of ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Phosphatidylinositol-3-OH kinase as a direct target of Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Signaling, mitogenesis and the cytoskeleton: where the action is.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Binding of NCK to SOS and activation of ras-dependent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Fighting cancer by attacking its blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

New perspectives in clinical oncology from angiogenesis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Selective inhibition of adhesion molecule expression by edelfosine (ET-18-OCH3) on human umbilical vein or microvascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Inhibition of angiogenesis in vivo by interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Oncogenes as inducers of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Gene therapy of malignant glioma via inhibition of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Comparative aspects of neoplastic invasion of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Growth factor expression in Breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Increased expression of mutant forms of p53 oncogene in primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Isolation and structure of urogastrone and its relationship to epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

Response to epidermal growth factors of cultured human mammary epithelial cells from benign tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.4.371

21 January 2018

Identifiers

DOI

10.1517/14712598.2.4.371

1 reference

3 August 2017

1 reference

PubMed ID

11955276